28 Jun MaxCyte
Jack Horgan, Vice President, Corporate Development and Strategy
April 15 | 11:15am | Salone dei Cavalieri, Section 2
Rockville, MD
(NASDAQ: MXCT)
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support innovative, cell-based research. MaxCyte builds best-in-class technology designed to facilitate complex engineering of a wide variety of cells and to drive the rapidly expanding cell therapy market forward. For over 20 years, MaxCyte has been a leader in developing transfection workflows and ventures beyond today’s processes to innovate tomorrow’s solutions. MaxCyte is headquartered in Rockville, Maryland’s I-270 Biotech Corridor.
